NCT00000596View on ClinicalTrials.gov

Diffuse Fibrotic Lung Disease

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

June 30, 1978

Study Completion Date

January 31, 1983

Conditions

Lung DiseasesPulmonary FibrosisSarcoidosis

Interventions

DRUG

prednisone

DRUG

cyclophosphamide

DRUG

dapsone

All Listed Sponsors

lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00000596 - Diffuse Fibrotic Lung Disease | Biotech Hunter | Biotech Hunter